Andrea Beyer

Risk assessment Expert

During the past 15 years Andrea has worked in the areas of Statistics and Epidemiology, both in the US and in Europe, for several private and public organizations. For the past 4 years, under a collaborative agreement with the University of Groningen, the Netherlands and the European Medicines Agency, Andrea formed part of a small team of experts providing research support for the EMA Benefit-Risk Methodology project. Her research areas of interest are measuring individual differences in risk attitude, risk perception, and elicitation of treatment preferences among patients, regulators and healthcare professionals. From October 2012 to December 2013 Andrea provided scientific leadership for the EMA Benefit-Risk Methodology project and since January 2014 has provided leadership for a European-wide study on extending benefit-risk methodologies to patients and healthcare professionals under Work Package 6 of the IMI-PROTECT project (